Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Patient Satisfaction 1Neutropenia 1Leiomyoma 1Central Line-associated Bloodstream Infection (CLABSI) 1Benign Female Reproductive System Neoplasm 1

Interventions

pegfilgrastim 30Filgrastim 29Cyclophosphamide 10Docetaxel 8pegylated granulocyte colony-stimulating factor 7Etoposide 7Cytarabine 7Ciprofloxacin 5Cefepime 5eflapegrastim 4Vancomycin 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4Fluorouracil 4Doxorubicin 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Methotrexate 3Levofloxacin 3Irinotecan 3Idarubicin 3Daunorubicin 3Cyclosporine 3Caspofungin 3Carboplatin 3trifluridine tipiracil drug combination 2plerixafor 2liposomal amphotericin B 2Vincristine 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neutropenia × Vascular Access Devices × Clear all
NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Universitair Ziekenhuis Brussel

Phase 4 Unknown
15 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡